跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irbe Speed HCT - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irbe Speed HCT
Approved
STANDARD
Irbe Speed HCT
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f401c62c9ac3ef47
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
f401c62c9ac3ef47
Drug Approval Philippines Name
Irbe Speed HCT
Product Name
Irbe Speed HCT
Registration Number
DRP-10539-01
Brand Name
Irbe Speed HCT
Generic Name
Irbesartan + Hydrochlorothiazide
Dosage Form
Tablet
Dosage Strength
150mg/ 12.5 mg
Manufacturer
Interphil Laboratories, Inc.
Distributor
SpeedMed Pharmaceuticals
Issuance Date
24 March 2022
Expiry Date
13 October 2026
Pharmacologic Category
Angiotensin II Receptor Blocker/Diuretic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f401c62c9ac3ef47
Type
Standard
Back to Philippines FDA Approvals